b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">29080044</PMID>\n        <DateCompleted>\n            <Year>2018</Year>\n            <Month>10</Month>\n            <Day>01</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2018</Year>\n            <Month>11</Month>\n            <Day>13</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1559-0100</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>59</Volume>\n                    <Issue>1</Issue>\n                    <PubDate>\n                        <Year>2018</Year>\n                        <Month>01</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Endocrine</Title>\n                <ISOAbbreviation>Endocrine</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Metformin effect on TSH in subclinical hypothyroidism: randomized, double-blind, placebo-controlled clinical trial.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>66-71</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s12020-017-1462-7</ELocationID>\n            <Abstract>\n                <AbstractText Label="INTRODUCTION">Non-randomized trials suggest that metformin may reduce TSH levels through unknown mechanisms.</AbstractText>\n                <AbstractText Label="OBJECTIVE">To evaluate whether metformin can reduce TSH levels in subjects with subclinical hypothyroidism.</AbstractText>\n                <AbstractText Label="PATIENTS AND METHODS">This is a randomized, double-blind, placebo controlled clinical trial with 3 months duration that enrolled 48 individuals, between 18 and 65 years, with subclinical hypothyroidism. The patients were randomized to the use of metformin 850\xe2\x80\x89mg or placebo twice a day for 3 months. The primary outcome was the absolute decrease in TSH levels. Secondary outcomes were changes in the clinical and laboratory assessment, as well as in blood pressure assessed by ambulatory blood pressure monitoring.</AbstractText>\n                <AbstractText Label="RESULTS">After 3 months, 93.75% of participants completed the follow-up. The post treatment value of TSH in the metformin and placebo groups were 6.48\xe2\x80\x89\xc2\xb1\xe2\x80\x893.11 and 7.02\xe2\x80\x89\xc2\xb1\xe2\x80\x893.28\xe2\x80\x89mIU/L, respectively (p\xe2\x80\x89=\xe2\x80\x890.57). Patients who achieved status of euthyroidism in the metformin and placebo groups were 21.7 and 18.2%, respectively (p\xe2\x80\x89=\xe2\x80\x890.76). There was no significant reduction of TSH within the groups [delta for TSH of 0.63\xe2\x80\x89\xc2\xb1\xe2\x80\x890.56 (p\xe2\x80\x89=\xe2\x80\x890.28) and 0.54\xe2\x80\x89\xc2\xb1\xe2\x80\x890.60\xe2\x80\x89mIU/L (p\xe2\x80\x89=\xe2\x80\x890.38), in metformin and placebo groups, respectively]. There was a small increase in HDL cholesterol (1.62\xe2\x80\x89\xc2\xb1\xe2\x80\x890.45 vs. 1.34\xe2\x80\x89\xc2\xb1\xe2\x80\x890.39\xe2\x80\x89mmol/L, p\xe2\x80\x89=\xe2\x80\x890.03) favoring the metformin group.</AbstractText>\n                <AbstractText Label="CONCLUSION">Since the sample size was small, the study was inconclusive and the results should be considered preliminary data of a study that needs to enroll 1626 patients to show a 0.5\xe2\x80\x89mIU/L difference in TSH between the groups, with 90% power.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Dornelles Severo</LastName>\n                    <ForeName>Mateus</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Programa de P\xc3\xb3s-Gradua\xc3\xa7\xc3\xa3o em Endocrinologia, Universidade Federal do Rio Grande do Sul, Faculdade de Medicina, Rua Ramiro Barcelos, 2400, 2\xc2\xb0 andar, Porto Alegre, RS, 90035-003, Brazil.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>St\xc3\xbcrmer Andrade</LastName>\n                    <ForeName>Thais</ForeName>\n                    <Initials>T</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Programa de P\xc3\xb3s-Gradua\xc3\xa7\xc3\xa3o em Endocrinologia, Universidade Federal do Rio Grande do Sul, Faculdade de Medicina, Rua Ramiro Barcelos, 2400, 2\xc2\xb0 andar, Porto Alegre, RS, 90035-003, Brazil.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Correa Junior</LastName>\n                    <ForeName>Vicente</ForeName>\n                    <Initials>V</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Programa de P\xc3\xb3s-Gradua\xc3\xa7\xc3\xa3o em Cardiologia, Universidade Federal do Rio Grande do Sul, Faculdade de Medicina, Rua Ramiro Barcelos, 2400, 2\xc2\xb0 andar, Porto Alegre, RS, 90035-003, Brazil.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Antonio Naujorks</LastName>\n                    <ForeName>Alexandre</ForeName>\n                    <Initials>A</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Universidade Federal de Santa Maria, Avenida Roraima, 1000, Santa Maria, RS, 97105-900, Brazil.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Gus</LastName>\n                    <ForeName>Miguel</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Programa de P\xc3\xb3s-Gradua\xc3\xa7\xc3\xa3o em Cardiologia, Universidade Federal do Rio Grande do Sul, Faculdade de Medicina, Rua Ramiro Barcelos, 2400, 2\xc2\xb0 andar, Porto Alegre, RS, 90035-003, Brazil.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Schaan</LastName>\n                    <ForeName>Beatriz D</ForeName>\n                    <Initials>BD</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Programa de P\xc3\xb3s-Gradua\xc3\xa7\xc3\xa3o em Endocrinologia, Universidade Federal do Rio Grande do Sul, Faculdade de Medicina, Rua Ramiro Barcelos, 2400, 2\xc2\xb0 andar, Porto Alegre, RS, 90035-003, Brazil. bschaan@hcpa.edu.br.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Hospital de Cl\xc3\xadnicas de Porto Alegre, Rua Ramiro Barcelos, 2350, 2\xc2\xb0 andar, Porto Alegre, RS, 90035-903, Brazil. bschaan@hcpa.edu.br.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n                <PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2017</Year>\n                <Month>10</Month>\n                <Day>27</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>United States</Country>\n            <MedlineTA>Endocrine</MedlineTA>\n            <NlmUniqueID>9434444</NlmUniqueID>\n            <ISSNLinking>1355-008X</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D008076">Cholesterol, HDL</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D010919">Placebos</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>9002-71-5</RegistryNumber>\n                <NameOfSubstance UI="D013972">Thyrotropin</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>9100L32L2N</RegistryNumber>\n                <NameOfSubstance UI="D008687">Metformin</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D058070" MajorTopicYN="N">Asymptomatic Diseases</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D001794" MajorTopicYN="N">Blood Pressure</DescriptorName>\n                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008076" MajorTopicYN="N">Cholesterol, HDL</DescriptorName>\n                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D007037" MajorTopicYN="N">Hypothyroidism</DescriptorName>\n                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>\n                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D007333" MajorTopicYN="N">Insulin Resistance</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008687" MajorTopicYN="N">Metformin</DescriptorName>\n                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>\n                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D010919" MajorTopicYN="N">Placebos</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D013972" MajorTopicYN="N">Thyrotropin</DescriptorName>\n                <QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="Y">Clinical trial</Keyword>\n            <Keyword MajorTopicYN="Y">Metformin</Keyword>\n            <Keyword MajorTopicYN="Y">Subclinical hypothyroidism</Keyword>\n            <Keyword MajorTopicYN="Y">TSH</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2017</Year>\n                <Month>08</Month>\n                <Day>13</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2017</Year>\n                <Month>10</Month>\n                <Day>17</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2017</Year>\n                <Month>10</Month>\n                <Day>29</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2018</Year>\n                <Month>10</Month>\n                <Day>3</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2017</Year>\n                <Month>10</Month>\n                <Day>29</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">29080044</ArticleId>\n            <ArticleId IdType="doi">10.1007/s12020-017-1462-7</ArticleId>\n            <ArticleId IdType="pii">10.1007/s12020-017-1462-7</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>Arch Intern Med. 2008 Oct 27;168(19):2070-80</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18955635</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Diabetes Care. 2009 Sep;32(9):1589-90</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19502536</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Arch Intern Med. 2007 Jul 23;167(14):1533-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17646608</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Pharm Ther. 1992 Apr;17(2):75-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">1583082</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Res Med Sci. 2014 Nov;19(11):1019-26</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25657744</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>JAMA. 2010 Sep 22;304(12):1365-74</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20858880</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Endocrine. 2007 Aug;32(1):79-82</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17992605</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Endocrinol Metab. 2002 Feb;87(2):489-99</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">11836274</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cochrane Database Syst Rev. 2007 Jul 18;(3):CD003419</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17636722</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Endocrinol Metab. 2006 Jan;91(1):225-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16219720</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Endocr Rev. 2008 Feb;29(1):76-131</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17991805</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Endocrinol Metab. 2014 Jan;99(1):E143-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24203069</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Arq Bras Endocrinol Metabol. 2013 Apr;57(3):166-83</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23681263</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Hypertens. 2007 May;25(5):993-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17414663</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Diab Vasc Dis Res. 2011 Jan;8(1):47-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21262871</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Pharmacol Rep. 2016 Dec;68(6):1115-1119</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27588386</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'